Factors Influencing Long-Term Local Recurrence, Distant Metastasis, and Survival in Patients with Soft Tissue Sarcoma of the Extremities Treated with Radiotherapy
Cancers · 07.05.2024 · 16 (10) · 1789
DOI: 10.3390/cancers16101789 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 07.05.2024. Verfasst von Arthur Lebas und 5 weiteren Autor:innen. Beteiligte Einrichtung: Radiotherapy Department, Institut de Cancérologie Strasbourg Europe (ICANS), 17 Rue Albert Calmette, BP 23025, 67033 Strasbourg, France. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The prognostic factors for extremity soft-tissue sarcomas (ESTSs) treated with multimodal surgery and radiotherapy (RT) remain a subject of debate across diverse and heterogeneous studies.
Methods
We retrospectively analyzed nonmetastatic ESTS patients treated with RT between 2007 and 2020 in Strasbourg, France. We assessed local control (LC), distant control (DC), overall survival (OS), and complications.
Results
A total of 169 patients diagnosed with localized ESTS were included. The median age was 64 years (range 21–94 years). ESTS primarily occurred proximally (74.6%) and in the lower limbs (71%). Most tumors were grade 2–3 (71.1%), deep-seated (86.4%), and had R0 margins (63.9%). Most patients were treated with helical tomotherapy (79.3%). The median biologically effective dose (BED) prescribed was 75 BEDGy4 (range 45.0–109.9). The median follow-up was 5.5 years. The 5- and 10-year LC, DC, and OS rates were 91.7%, 76.8%, and 83.8% and 84.2%, 74.1%, and 77.6%, respectively. According to the univariate analysis, LC was worse for patients who received less than 75 BEDGy4 (p = 0.015). Deep tumors were associated with worse OS (p < 0.05), and grade 2–3 and undifferentiated pleomorphic sarcoma (UPS) were linked to both shorter DC and shorter OS (p < 0.05). IMRT was associated with longer LC than 3DRT (p = 0.018). Multivariate analysis revealed that patients with liposarcoma had better OS (p < 0.05) and that patients with distant relapse had shorter OS (p < 0.0001).
Conclusion
RT associated with surgical resection was well tolerated and was associated with excellent long-term rates of LC, DC, and OS. Compared with 3DRT, IMRT improved local control. Liposarcoma was a favorable prognostic factor for OS. Intermediate- and high-grade tumors and deep tumors were associated with lower DC and OS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Radiotherapy Department, Institut de Cancérologie Strasbourg Europe (ICANS), 17 Rue Albert Calmette, BP 23025, 67033 Strasbourg, France.
- Radiotherapy Department, Léon Bérard Center, 28 Rue Laennec, 69008 Lyon, France.
- Orthopedic Surgery Department, University Hospital of Hautepierre, 1 Rue Molière, 67200 Strasbourg, France.
- Faculty of Medicine, University of Strasbourg, 4 Rue Kirschleger, 67000 Strasbourg, France.
- Radiobiology Laboratory, Centre Paul Strauss, IIMIS-Imagerie Multimodale Integrative en Santé, ICube, Strasbourg University, 67081 Strasbourg, France.
ORCID-Profile: Waisse Waissi, Isabelle Chambrelant, Georges Noel
Zitieren
APA
Lebas, A., Le Fevre, C., Waissi, W., Chambrelant, I., Brinkert, D., & Noel, G. (2024). Factors Influencing Long-Term Local Recurrence, Distant Metastasis, and Survival in Patients with Soft Tissue Sarcoma of the Extremities Treated with Radiotherapy. Cancers, 16(10), 1789. https://doi.org/10.3390/cancers16101789
Vancouver
Lebas A, Le Fevre C, Waissi W, Chambrelant I, Brinkert D, Noel G. Factors Influencing Long-Term Local Recurrence, Distant Metastasis, and Survival in Patients with Soft Tissue Sarcoma of the Extremities Treated with Radiotherapy. Cancers. 2024;16(10):1789. doi:10.3390/cancers16101789
BibTeX
@article{Lebas2024,
author = {Lebas, Arthur and Le Fevre, Clara and Waissi, Waisse and Chambrelant, Isabelle and Brinkert, David and Noel, Georges},
title = {Factors Influencing Long-Term Local Recurrence, Distant Metastasis, and Survival in Patients with Soft Tissue Sarcoma of the Extremities Treated with Radiotherapy},
journal = {Cancers},
year = {2024},
volume = {16},
number = {10},
pages = {1789},
doi = {10.3390/cancers16101789}
}
EUVIMED